⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

ResMed made substantial revisions to its risk disclosure, with 16 of 28 identified risks modified substantively, while adding 4 new risks and removing 2 existing ones. Notable changes include the removal of FDA regulatory delay risks and securities market ownership risks, offset by the addition of manufacturing quality standards compliance risks. The 2023 filing demonstrates a shift toward operational and regulatory compliance risks while de-emphasizing market-related risk factors.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing RESMED INC. AND SUBSIDIARIES 🔒

🟢 New in Current Filing We are subject to substantial regulation related to quality standards applicable to our manufacturing and quality processes. Our failure to comply with these standards could have an adverse effect on our business, financial 🔒

🟢 New in Current Filing RESMED INC. AND SUBSIDIARIES 🔒

🔴 No Match in Current Filing Product sales, introductions or modifications may be delayed or canceled as a result of FDA regulations or similar foreign regulations, which could cause our sales and profits to decline. Unless a product is exempt, before we can 🔒

🔴 No Match in Current Filing Risks Related to the Securities Markets and Ownership of Our Common Stock 🔒

🟡 Modified RESMED INC. AND SUBSIDIARIES 🔒

🟡 Modified Risks Related to Our Business and Industry 🔒

🟡 Modified RESMED INC. AND SUBSIDIARIES 🔒

🟡 Modified Risks Related to the Securities Markets and Ownership of Our Common Stock 🔒

🟡 Modified RESMED INC. AND SUBSIDIARIES 🔒

🟡 Modified Risks Related to Manufacturing, IT Systems, Commercial Operations and Plans for Future Growth 🔒

🟡 Modified RESMED INC. AND SUBSIDIARIES 🔒

22 changes in this historical filing

Historical year-over-year comparisons (2023 vs 2022 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →